Back to Agenda
[V7-S5] Introduction to database study II - Example for RMP
Session Chair(s)
Chieko Ishiguro, PHD, MPH
Section Chief of Clinical Epidemiology, Department of Data Science, National Center for Global Health and Medicine, Japan
Rei Maeda
Consultant, Independent Consultant for Drug PV, Japan
Database studies based on secondary data analysis of automated largescale health care databases, such as claims data and electronic medical records, have been widely acknowledged and employed in postmarketing evaluations overseas. This session will outline and discuss the current issues and challenges in fully introducing and quickly realizing database studies in Japan.
Speaker(s)
Kotonari Aoki, MS
Head of Real World Data Science Dept. Drug Safety Div., Chugai Pharmaceutical Co., Ltd., Japan
Post Expected to RMP of DB Research - 2017, 2018
Kasumi Daidoji, PHD, RPH
Associate Director, Clinical Planning & Development Dept., Medical Headquarters, Eisai Company, Ltd., Japan
Approach for Utilization of Medical DB
Tatsuo Kagimura, MPH
Chief, Department of Analysis, Translational Research Informatics Center (TRI), Japan
Case Control Ctudy Design in Point of View of Cohort Study
Gerald Dal Pan, MD, MHS
Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Have an account?